The plaintiffs allege that use of the drugs, known as glucagon-like peptide-1 (GLP-1) receptor agonists can result in severe and life-threatening gastrointestinal problems including gastroparesis
Step one: baseline documentation Before starting any treatment, document your current status
Choosing the right IV therapy starts with understanding your priorities
If you're somebody who has, uh, connective tissue issues, you have, uh, hypermobility work with a physical trainer or occupational therapist because you still need mobility
[3] [4] The cardiovascular benefits observed were associated with improved glycemic control and weight loss, though the precise mechanisms contributing to MACE reduction remain under investigation
Weight regain is possible if healthy habits are not in place